Acute vision loss in Guillain–Barré syndrome: A case series and review of literature
Tóm tắt
Acute vision loss in Guillain–Barré syndrome is rarely reported in literature. No case of vision loss in Guillain–Barré syndrome due to Angle closure glaucoma has been reported in AIDP variant GBS. We report three patients with an acute inflammatory demyelinating polyradiculoneuropathy subtype of GBS who developed acute vision loss during the course of disease. Two patients had autonomic dysfunction with hypertension, in which one patient presented with painful acute vision loss and was diagnosed with Angle closure glaucoma and another patient had painless vision loss which was due to posterior reversible encephalopathy syndrome. Third patient presented with bilateral papilledema with raised cerebrospinal fluid protein and intracranial pressure. Vision in all the three patients improved after treatment. Patient with GBS, with autonomic dysfunction and hypertension or elevated cerebrospinal fluid protein may present with acute vision loss during the course of the disease. Early diagnosis and management help to improve vision and prevent permanent vision loss in these patients.
Tài liệu tham khảo
Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain–Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology. 2011;36(2):123–33.
Kalita J, Misra UK, Goyal G, Das M. Guillain–Barré syndrome: subtypes and predictors of outcome from India. J Peripher Nerv Syst. 2014;19(1):36–43.
Leonhard SE, Mandarakas MR, Gondim FAA, Bateman K, Ferreira MLB, Cornblath DR, et al. Diagnosis and management of Guillain–Barré syndrome in ten steps. Nat Rev Neurol. 2019;15(11):671–83.
Brittain CJ, Lake D. Acute angle closure in Miller Fisher syndrome. Eye (Lond). 2006;20:739–40.
Baxter JM, Alexander P, Maharajan VS. Bilateral, acute angle-closure glaucoma associated with Guillain–Barre syndrome variant. BMJ Case Rep. 2010;21(2010): bcr1120092487.
Ryu WY, Kim JK, Jin SW, Shim DH. Acute angle-closure glaucoma in a patient with miller fisher syndrome without pupillary dysfunction. J Glaucoma. 2015;24(2):e5-6.
Han J, Ji Y, Cao D, Kang Z, Zhu J. Miller Fisher syndrome with acute angle-closure glaucoma as the first manifestation: a case report. Medicine (Baltimore). 2017;96(50): e9201.
Rawat N, Khanna M, Rukmani R, Haldar P. Autonomic dysfunction in patients with Gullain–Barre syndrome in sub-acute phase. J Clin Diagn Res. 2019;13(6):LC16–20.
Gilpin S, Moersch FP, Kernohan JW. Polyneuritis: a clinical and pathologic study of a special group of cases frequently referred to as instances of neuronitis. Arch Neurol Psych. 1936;35(5):937–63.
Morley JB, Reynolds EH. Papilloedema and the Landry–Guillain–Barre syndrome. Case reports and a review. Brain. 1966;89(2):205–22.
Doxaki C, Papadopoulou E, Maniadaki I, Tsakalis NG, Palikaras K, Vorgia P. Case report: intracranial hypertension secondary to Guillain–Barre syndrome. Front Pediatr. 2021;8: 608695.
Kharbanda PS, Prabhakar S, Lal V, Das CP. Visual loss with papilledema in Guillain–Barre syndrome. Neurol India. 2002;50(4):528–9.
Mathis S, Le Masson G, Soulages A, Duval F, Solé G, Boissonnot M, et al. Papilledema and peripheral neuropathies. Neurologist. 2019;24(6):185–93.
Gross FJ, Mindel JS. Pseudotumor cerebri and Guillain–Barré syndrome associated with human immunodeficiency virus infection. Neurology. 1991;41(11):1845–6.
Wen HJ. Acute bilateral vision deficit as the initial symptom in Guillain–Barre syndrome: a case report. Exp Ther Med. 2018;16(3):2712–6.
Joynt RJ. Mechanism of production of papilledema in the Guillain–Barre syndrome. Neurology. 1958;8(1):8–12.
Jain RS, Kumar S, Aggarwal R, Kookna JC. Acute aseptic meningitis due to intravenous immunoglobulin therapy in Guillain–Barré syndrome. Oxf Med Case Rep. 2014;2014(7):132–4.
Fischer M, Schmutzhard E. Posterior reversible encephalopathy syndrome. Med Klin Intensivmed Notfmed. 2016;111:417–24.
Bavikatte G, Gaber T, Eshiett MU. Posterior reversible encephalopathy syndrome as a complication of Guillain–Barré syndrome. J Clin Neurosci. 2010;17:924–6.
Elahi A, Kelkar P, St Louis EK. Posterior reversible encephalopathy syndrome as the initial manifestation of Guillain–Barré syndrome. Neurocrit Care. 2004;1:465–8.
Chen A, Kim J, Henderson G, Berkowitz A. Posterior reversible encephalopathy syndrome in Guillain–Barré syndrome. J Clin Neurosci. 2015;22(5):914–6.
Joshi S, Prentice D, van Heerden J, Chemmanam T. Guillain–Barré syndrome and posterior reversible leukoencephalopathy syndrome: a rare association. BMJ Case Rep. 2020;13(4): e234184.
Ramakrishnan S, Kannan B, Kannan A, Venkatesan EP. Vision loss in Guillain–Barre syndrome: is it a complication of Guillain–Barre syndrome or just a coincidence? J Ophthalmic Vis Res. 2016;11(3):340–1.
Nabi S, Rajput HM, Badshah M, Ahmed S. Posterior reversible encephalopathy syndrome (PRES) as a complication of Guillain–Barre’ syndrome (GBS). BMJ Case Rep. 2016;2016: bcr2016216757.
Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334(8):494–500.
Blackburn D, Chavada G, Dunleavy D, Hoggard N, Sharrack B, Ponnusamy S, et al. Guillain–Barre syndrome (GBS) presenting with posterior reversible encephalopathy syndrome. J Neurol Neurosurg Psychiatry. 2011;82: e4.
Nakajima M. Posterior reversible encephalopathy complicating intravenous immunoglobulins in a patient with miller-fisher syndrome. Eur Neurol. 2005;54(1):58–60.
Ribeiro BN, Salata TM, Borges RS, Marchiori E. Posterior reversible encephalopathy syndrome following immunoglobulin therapy in a patient with Miller–Fisher syndrome. Radiol Bras. 2016;49(1):58–9.